Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2005
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592704A Adsorbents and uses thereof
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592622A Orodispersible tablets containing fexofenadine
03/09/2005CN1592613A Drug form with different shapes of cores and shells
03/09/2005CN1592612A Drug form with core and shell
03/09/2005CN1592611A Modified release dosage forms
03/09/2005CN1592610A Modified release dosage forms
03/09/2005CN1590545A Small interference RNA molecule (siRNA) of attacking SARS virus mRNA melecule and application
03/09/2005CN1590399A Artificial synthesized deoxyoligonucleotide containing CpG single chain and anti single strand linear chain RNA virus
03/09/2005CN1589900A Medical health protection use of globe fish glue
03/09/2005CN1589899A Application of recombination now type composite interferon in preventing and treating SARS
03/09/2005CN1589898A Application of human interferon alpha 2a in preparation of medicine for preventing and treating SARS
03/09/2005CN1589896A Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication
03/09/2005CN1589892A Medicinal composition for treating acute, chronic pharyngolaryngitis and its preparation method
03/09/2005CN1589888A Traditional Chinese medicine for SARS acute period treatment and its preparation method
03/09/2005CN1589885A Medicine for treating bronchus asthma
03/09/2005CN1589873A Medicinal spraying agent for treating nasitis
03/09/2005CN1589856A External use nose drops agent for treating common cold and its preparation method
03/09/2005CN1589854A Nose drop agent for treating common cold and its preparation method
03/09/2005CN1589852A External use nose drop agent for treating common cold and its preparation method
03/09/2005CN1589829A Medicine for anticancer, anti-inflammation, calm panting
03/09/2005CN1589827A Medicine for treating common cold and cough
03/09/2005CN1589826A Medicine for settling cough and eliminating phlegm
03/09/2005CN1589824A Medicine for nourishing yin and clearing lung, settling cough and eliminating phlegm
03/09/2005CN1589823A Medicine for dispelling wind stopping cough, eliminating phlegm dissipating bond
03/09/2005CN1589810A Method of preventing SARS
03/09/2005CN1589794A Hydrobromic acid dextro methaphen oral cavity disintegretion tablet and its preparation method
03/09/2005CN1589789A Preparation of hydrobromic acid dextro methaphen and beta cyclodeatrin compounding object
03/09/2005CN1589783A N-[O-(P-trimethyl acetoxyl benzene sulfonamide) benzoyl] glycine mono sodium salt tetrahydrate
03/09/2005CN1192101C Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/09/2005CN1192025C Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191852C Vaccine
03/09/2005CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof
03/09/2005CN1191848C Chinese medicine prepn for treating throat and oral cavity diseases and its prepn process
03/09/2005CN1191845C Medicine for treating upper respiratory tract infection and its prepn
03/09/2005CN1191844C Smelling treated Chinese medicine
03/09/2005CN1191840C Common cold treating Chinese medicine and its prepn
03/09/2005CN1191836C Use of hydrogenous medicament active component in medical product preparation
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/03/2005WO2005019245A1 Heptadepsin
03/03/2005WO2005019203A1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
03/03/2005WO2005019182A1 Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
03/03/2005WO2005018529A2 Phenoxiacetic acid derivatives
03/03/2005WO2005007142A3 Liquid compositions comprising formoterol
03/03/2005WO2004105793A3 Soluble clca-1 and antagonists to clca-1
03/03/2005WO2004071395A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r)
03/03/2005WO2004071383A3 New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
03/03/2005US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer
03/03/2005US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction
03/03/2005US20050049238 Heterocyclic retinoid compounds
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides
03/03/2005US20050049190 Cation conducting gabaa receptors and their use
03/03/2005US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050048026 Remedies for ischemic diseases
03/03/2005US20050048024 Compounds for use as surfactants
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005CA2536293A1 Methods of treating copd and pulmonary hypertension
03/03/2005CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation
03/03/2005CA2535714A1 Phenoxyacetic acid derivatives
03/02/2005EP1510579A2 Use of heregulin as an epithelial cell growth factor
03/02/2005EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
03/02/2005EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1510214A2 8a-azalides as veterinary antimicrobial agents
03/02/2005EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2)
03/02/2005EP1509767A1 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
03/02/2005EP1509621A1 Treatment with cytokines for alzheimer's disease
03/02/2005EP1509618A2 Autoimmune conditions and nadph oxidase defects
03/02/2005EP1509541A2 Novel recombinant anticoagulant proteins
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 878